chronic cisplatin induced nephropathy

chronic cisplatin induced nephropathy - chronic cisplatin induced nephropathy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON43000

Enrollment

500

Registered

2017-01-12

Start date

2017-04-05

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cisplatin nephropathy kidney injury due to cisplatin

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: age * 18 years old last gift cisplatin more than 1 year ago all doses of cisplatin all original oncological diagnoses

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
number of patients with chronic cisplatin nephropathy (chronic kidney injury defined as a reduced GFR or biochemical signs of tubulopathy).	—

Secondary

Measure	Time frame
Quality of life in patients with nephropathy versus no signs of nephropathy	—

Countries

Netherlands

Outcome results